Monthly Archives: November 2025

Japan’s economy shrank as a result of Trump’s tariffs

Posted on by
Reply

Japan’s economy showed signs of growth earlier in the year, but economists have predicted that the optimistic reports were inflated as exporters rushed to beat U. S. tariffs. Japan’s largest export is vehicles, and its top destination for exports is the United States. According to a government economic report, Japan’s gross domestic product fell 0. 4% in the July to September quarter on a quarter-by-quarter basis. The decline was the country’s first contraction in six quarters. The annualized contraction, however, was less than expected, according to Reuters, which anticipated a 2. 5% annualized contraction this quarter. Japanese automakers have seen exports plummet, and residential housing investments have also contributed to the contraction, according to the news outlet. TRUMP HAILS JAPAN’S NEW PRIME MINISTER, SAYS US IS ‘ALLY AT THE STRONGEST LEVEL’ Trump visited Tokyo in late October during his trip through Asia to meet the new Prime Minister, Sanae Takaichi, for the first time.
https://www.washingtonexaminer.com/policy/economy/3889055/japan-economy-shrank-result-trump-tariffs/

Could Phillies Pivot From Kyle Schwarber To 5-Time All-Star?

Posted on by
Reply

The Philadelphia Phillies’ offense could look a bit different next year. That is because of the fact that Kyle Schwarber is a free agent right now after being a key cog in the middle of the Phillies lineup over the last four years. Schwarber earned two All-Star nods in Philadelphia and is coming off a season in which he hit 56 homers and drove in 132 runs, both of which led the National League. Bringing Schwarber back should be a priority and it has been reported over and over again that it is for the organization. But, what if he leaves? MLB. com’s Mark Feinsand listed five teams as “potential suitors” for New York Mets star slugger Pete Alonso. The Phillies cracked Feinsand’s list as a team to watch if they pivot from Schwarber. “Philadelphia’s No. 1 priority appears to be re-signing Kyle Schwarber, but if the National League MVP runner-up signs elsewhere, Alonso could be a target to replace the slugger,” Feinsand wrote. “Signing Alonso would mean either moving Bryce Harper back to right field, or using Alonso and Harper as a first base/DH combo, but adding a big bat should be in the cards for the Phillies if they’re unable to retain Schwarber.” If the Phillies lose Schwarber, there isn’t a better replacement available purely from a power perspective than Alonso. The five-time All-Star has 264 homers over the last seven seasons, including 38 long balls in 2025. The fit with the Phillies isn’t great because first base isn’t open. But Alonso’s agent, Scott Boras, didn’t close the door on the idea of Alonso seeing more time as a designated hitter in his next contract. That’s the only way an idea like this works for the Phillies.
https://www.newsweek.com/could-phillies-pivot-from-kyle-schwarber-to-5-time-all-star-11059504

Would Charlotte crime justify deploying National Guard?

Posted on by
Reply

Fraternal Order of Police and 3 NC congressmen want President Trump to deploy National Guard to fight Charlotte crime. Others are dubious. Would Charlotte crime justify deploying National Guard? is a story from Carolina Public Press, an award-winning independent newsroom. Our breakthrough journalism shines a light on the critical overlooked and under-reported issues facing North Carolina’s more than 11 million residents. Please consider making a contribution to support our journalism.
https://carolinapublicpress.org/73445/charlotte-crime-national-guard/

Full Truck Alliance Co. Ltd. (YMM) Q3 2025 Earnings Call Transcript

Posted on by
Reply

Mao Mao Head of Investor Relations Thank you, operator. Please note that today’s discussion will contain forward-looking statements relating to the company’s future performance, which are intended to qualify for the safe harbor from liability as established by the U. S. Private Securities Litigation Reform Act. Such statements are not guarantees of future performance and are subject to certain risks and uncertainties, assumptions and other factors. Some of these risks are beyond the company’s control and could cause actual results to differ materially from those mentioned in today’s press release and discussion. A general discussion of the risk factors that could affect FTA’s business and financial results is included in certain filings of the company with the SEC. The company does not undertake any obligation to update this forward-looking information, except as required by law. During today’s call, management will also discuss certain non-GAAP financial measures for comparison purpose only. For a definition of non-GAAP financial measures and a reconciliation of GAAP to non-GAAP financial results, please see the earnings release issued earlier today.
https://seekingalpha.com/article/4844576-full-truck-alliance-co-ltd-ymm-q3-2025-earnings-call-transcript?source=feed_all_articles

Big data, big challenge – how life sciences turn information overload into insight

Posted on by
Reply

Big data refers to extremely large and complex data sets that are so massive and intricate they cannot be managed or analyzed by traditional data processing tools. In life sciences, these vast datasets are generated every day from experiments, clinical records, and screening programs. Sequencing just one human genome, for example, can produce more than 200 gigabytes of raw data. This scale of information is pivotal for discovery, but only if it can be organized, and made usable. While data is the bedrock of the life sciences industry, big data introduces practical challenges, not just in storage and security, but in turning information into actionable insight. The benefits of big data in life sciences Identifying trends early: Big data allows scientists to detect patterns that help predict disease outbreaks, track disease progression, and guide preventative measures. This can ultimately save lives. Designing targeted medicine: By combining genomic, clinical, and lifestyle data, researchers can design treatment plans tailored to individual patients. This improves outcomes and accelerates precision medicine. Making better decisions: Big data analytics empowers researchers, clinicians, and policymakers to make more informed, evidence-based decisions about care and resource allocation. The complexities of big data in life sciences While big data certainly offers great value for life sciences, it’s worth briefly considering some of the challenges that make managing scientific data uniquely complex. These can be grouped into two broad categories: infrastructure and data itself. Infrastructure complexity The scale and speed of data generation in biopharma R&D demand flexible, high-performance infrastructure. Traditional on-premise systems struggle to keep up with the volume and velocity of scientific data, especially as instruments, sensors, and models generate continuous streams of information. Cloud-based, software-as-a-service (SaaS) platforms however are helping to overcome this barrier by providing elastic scalability, built-in security, and simplified data access. This allows scientists to focus on research rather than infrastructure management. Data diversity and integration In life science research, data comes in many forms structured clinical trial tables, semi-structured instrument outputs, and unstructured lab notes or images. This “variety” makes it difficult to consolidate and analyze results across experiments and teams. Effective big-data management therefore relies on platforms that can unify these sources, maintain scientific context, and support collaboration across discovery, development, and clinical environments. Responsible data management in biopharma R&D Managing big data responsibly presents significant challenges for life sciences organizations, from protecting sensitive information to ensuring that data remains usable and connected across the research landscape. The sheer volume of data being generated requires ever-larger, more efficient storage and processing solutions, whilst also creating difficulties for researchers, who must sift through overwhelming amounts of information to find what is relevant and actionable. At the same time, the need to protect this data has never been greater. As personal and genomic information becomes more widely collected, organizations must ensure that it is handled securely and in compliance with data protection regulations. Any lapse in governance risks not only regulatory penalties but also the erosion of public trust. The rise of AI analysis tools adds another layer of complexity. While AI can act as a powerful collaborator in managing and interpreting big data, it requires careful oversight, particularly when handling sensitive health information. Systems must be transparent, accountable, and rigorously validated to prevent errors or data breaches. A recent McKinsey report notes that AI’s promise lies in augmenting human capability, not replacing it, but that collaboration must be built on trust. There is also the potential for bias in AI-driven systems. According to Harvard Online, “Big data algorithms may exhibit bias and discrimination based on factors such as race, gender, and socioeconomic status. Biased algorithms can perpetuate existing inequalities and undermine trust in automated decision-making systems.” Scientific advances are meant to benefit everyone. Addressing these ethical and technical concerns is essential, not only to uphold fairness and accuracy but also to ensure that discoveries are based on reliable, representative data. But in life sciences, protecting data is only half the battle. To drive discovery, data must also move freely and retain meaning across the research and clinical continuum. The bottleneck in healthcare innovation today is no longer discovery. It is integration. The next evolution in scientific informatics lies in creating a digital thread that connects data across systems and stages, so that every insight, sample, and result remains part of a continuous picture. Laboratory Information Management Systems (LIMS) and other data platforms are most powerful when they not only collect data but allow scientists to make sense of it. The goal is not more data but connected data that fuels better science. Strategies for big data management The scale and speed of data generation in life sciences demand flexible, scalable, and centralized systems. Cloud-based platforms are increasingly preferred for their ability to consolidate data across instruments, systems, and locations. Combined with AI and machine learning, they enable researchers to analyze large datasets, identify patterns, and predict emerging trends. Yet, despite this potential, the growth of big data has outpaced many organizations’ ability to manage it effectively. The challenge now is not collecting more data, it is connecting it, contextualizing it and turning it into valuable insight. We’ve featured the best cloud database.
https://www.techradar.com/pro/big-data-big-challenge-how-life-sciences-turn-information-overload-into-insight

Scientists Sequenced the DNA of the ‘Last Neanderthal’—and It Alters Human History

Posted on by
Reply

Here’s what you’ll learn when you read this story: In 2015, a paleoanthropology team discovered jaw remains of a roughly 42, 000-year-old Neanderthal in France. Over the next several years, the team, led by Ludovic Slimak, found more of the Neanderthal’s remains and began to analyze its genome. Despite its proximity to other groups of Neanderthals and the era’s modern humans, the lineage of the specimen, dubbed “Thorin,” found by Slimak managed to stay totally isolated from groups of other early beings. “There is nothing like looking, if you want to find something,” says Thorin Oakenshield in J. R. R. Tolkien’s beloved fantasy novel The Hobbit. “You certainly usually find something, if you look, but it is not always quite the something you were after.” For example, in 2015, paleoanthropologist Ludovic Slimak made a remarkable discovery at Grotte Mandrin, a cave in Rhône Valley, France. He and his team had been working the area since 1998 to find remnants of humanity’s prehistoric forbearers, and after 17 years, they certainly found something: a piece of a jaw belonging to a Neanderthal. As the years went on, more and more remains of this Neanderthal were discovered. “I began to find {remnants of the Neanderthal’s jaw} in 2015,” Slimak told the New Statesman in 2022, “but each year we find one tooth, or one fragment of bone.” Slimak determined that this particular Neanderthal lived 42, 000 years ago, towards the end of that species’ time on this planet. As such, he named the Neanderthal Thorin after the Tolkien character. “Thorin in the Hobbit is one of the last dwarf kings under the mountain and the last of its lineage,” Slimak told the website IFLScience. “Thorin the Neanderthal is also an end of lineage. An end of a way to be human.” Ludovic Slimak, photographed in 2022, poses with the milk tooth of both a homo sapien and a neanderthal To confirm his suspicions about Thorin’s age and attempt to glean more information about not just when but how this particular specimen lived, Slimak and his colleagues had Thorin’s genome analyzed. The results, published in the journal Cell Genomics, show that Thorin’s lineage managed to stay isolated from the rest of the Neanderthal population, “in spite of the fact that other groups lived nearby.” Nearly a decade before ever finding Thorin, Slimak had already theorized that any Neanderthals who had resided in the Rhône Valley would have been different from those in the surrounding areas. His assessment, at that point, was based on the stone tools found at various sites, noting that those in the Rhône Valley didn’t reflect the newer tool-making style found at other locations. “It turns out that what I proposed 20 years ago was predictive,” Slimak told the publication Live Science. “The population of Thorin had spent 50 millennia without exchanging a single gene with the classical Neanderthal populations.” The analysis showed that Thorin had “high genetic homozygosity,” which indicates inbreeding in the lineage’s recent past. It also offers no evidence of interbreeding with modern humans of the time. “Everything must be rewritten about the greatest extinction in humanity and our understanding of this incredible process that will lead Homo sapiens to remain the only survival of humanity,” Slimak said in assessing what this discovery means. “How can we imagine populations that lived for 50 millennia in isolation while they are only two weeks’ walk from each other? All processes need to be rethought.”.
https://www.popularmechanics.com/science/archaeology/a69457323/dna-last-neanderthal-sequenced/

U.S. Aluminum Chlorohydrate Market Size & Revenue Analysis 2035

Posted on by
Reply

According to the latest research publication, U. S. Aluminum Chlorohydrate Market, by Prophecy Market Insights, the U. S. Aluminum Chlorohydrate Market market is projected to witness substantial growth over the next decade. This comprehensive report offers detailed insights into market size, trends, segmentation, regional performance, and competitive landscape. The report is designed to empower business leaders and stakeholders with essential intelligence, enabling informed investment decisions and revealing potential gaps and opportunities within the U. S. Aluminum Chlorohydrate Market industry. Report Details: Base Year: 2024 Forecast Period: 2025-2035 U. S. Aluminum Chlorohydrate Market Overview The report explores the historical performance of the U. S. Aluminum Chlorohydrate Market market and projects future developments based on regional dynamics and other critical variables. It highlights cutting-edge innovations and emerging trends that are expected to drive the industry forward. To provide a comprehensive view, the report analyzes sales volume, market value, competition, and includes a detailed SWOT analysis. Request the PDF Brochure: In-Depth Market Analysis The study segments the market by type, key players, deployment models, and applications, covering: Product Types: In-depth look at the various product offerings in the U. S. Aluminum Chlorohydrate Market market. Key Players: Profiles of leading companies, their market share, and strategic initiatives. Applications: Evaluation of how U. S. Aluminum Chlorohydrate Market products are utilized across multiple industries. U. S. Aluminum Chlorohydrate Market Segmentation The report breaks down the market into targeted segments to offer a clearer view of the competitive environment and growth areas. Segmentation Overview: By Type-Solid and Liquid By Application-Cosmetics, Water Treatment, Pharmaceutical, and Others Key Takeaways Comprehensive analysis of all major market segments Focus on strategic positioning and regional expansion Granular segmentation and regional insights In-depth competitive landscape evaluation Identification of future growth opportunities Competitive Landscape This section evaluates the strategies of top market players, including: Business development strategies (e. g., M&A, partnerships, new product launches) SWOT analysis and market positioning Revenue trends and innovation benchmarks Highlighted Companies: Chemtrade Logistics Inc. Kemira Oyj USALCO LLC Holland Company Zhejiang NetSun Co. Ltd. Parchem fine & specialty chemicals The GEO Group Inc. Innova Corporation Co. Ltd. Visual aids such as graphs, tables, and charts are used throughout to present data clearly and concisely. Data-Driven Insights The report is grounded in data and provides a thorough look at the current market environment, while also forecasting how key drivers will influence growth throughout the forecast period. Development Outlook & Trends Key topics include: Evolving sales channels Raw material trends (upstream) and demand behavior (downstream) Profitability forecasting to support strategic innovation and product expansion within the U. S. Aluminum Chlorohydrate Market market Regional Insights A regional deep dive highlights: Growth-driving trends in major regions Sales performance, revenue, pricing, and gross margins Regional microeconomic factors influencing market behavior The major regions and sub-regions covered in the research report are: North America (US, Canada) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia Pacific (China, Japan, Korea, India, Southeast Asia, Australia, and Rest of Asia Pacific) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and Rest of the Middle East and Africa) Key Questions Answered in Report: What are the key factors driving the U. S. Aluminum Chlorohydrate Market growth? Which region is projected to have better demand for products/services in the market? What are the emerging opportunities market participants can capitalize on? What are the operating strategies adopted by major market participants? How will strategic initiatives impact the market growth in the upcoming years? Which segment is projected to witness significant growth during the forecast period? Conclusion The U. S. Aluminum Chlorohydrate Market research report offers an all-inclusive analysis for anyone involved or interested in the rapidly growing market. It covers all the major market aspects, including market segmentation, competitive landscape, and top players. Also, customization options are available with respect to product, application, and region. Author: Authored by Riya B. More, Research Associate at Prophecy Market Insights. This comprehensive analysis is grounded in an extensive blend of primary interviews, industry expert consultations, and in-depth secondary research. It provides strategic insights into the evolving dynamics, competitive landscape, and emerging opportunities within the global U. S. Aluminum Chlorohydrate Market. About Prophecy Market Insights Prophecy Market Insights is a trusted name in market research, delivering actionable intelligence and tailored reports across various industries. Our expert team provides accurate, reliable, and timely insights to help businesses stay competitive and make strategic.
https://www.prnewsreleaser.com/news/123004